Notice of 34th Annual General Meeting of Vista Pharmaceuticals Limited to be held on Tuesday 30th September 2025
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Vista Pharmaceuticals (BSE: 524711) has dispatched the notice for its 34th AGM to be held on Tuesday, September 30, 2025 at 11:00 AM via video conferencing. Shareholders will vote on adopting FY25 audited financials, re-appointing two directors retiring by rotation, and re-appointing M/s A.M Reddy & D.R. Reddy as statutory auditors for another 5-year term (till the 39th AGM in 2030) at a proposed audit fee of Rs. 2 lakh per year. On the special business side, M/s Aakanksha Dubey & Co is proposed as the new secretarial auditor for 5 years, and three directors — Mr. Murali Meraga (Managing Director), Mr. Pavan Sathvik Gilaka and Dr. Dhananjaya Alli (both Whole-Time Directors) — are being re-appointed for 3-year terms from October 20, 2025 to October 19, 2028, notably all without any remuneration. Remote e-voting opens on September 27 and closes on September 29, with the cut-off date for voting eligibility set as September 23, 2025.
Routine governance agenda with no major business or capital-related proposals — resolutions are largely confirmatory re-appointments of existing management and auditors. The re-appointments being without remuneration suggest the promoter/executive directors continue to forgo salary, which is broadly neutral for shareholders.